Axiom MRC has updated all it's market research reports with the Economic Impact Analysis of COVID19 Pandemic on the market. Our team of analyst are following Comprehensive Three Dimensional (3D) Research Methodology along with large number primary interviews with key industry participants to bring insightful market reports to meet the current market requirements.
Photon-counting computed tomography (CT) is a computed tomography technique currently under research and development. A photon-counting CT system employs a photon-counting detector (PCD) that registers the interactions of individual photons. By keeping track of the deposited energy in every interaction, the detector pixels of a PCD each record an approximate energy spectrum, creating it a spectral or energy-resolved CT technique. The photon-counting CT is a very weak optical pulse detection tool based on the direct detection quantum limit theory. This technology has the capability to significantly increase scientific performance for cardiology, oncology, neurology, and plenty of different scientific CT applications. Photon-counting CT has the promise to further expand the scientific capabilities of conventional CT, which includes the visualization of minute details of organ structures, more accurate material density size and improved tissue characterization. The demand for photon counting-CT is growing broadly with the growing occurrence of numerous chronic disorders.
Photon-counting CT has the promise to similarly expand the clinical capabilities of conventional CT, such as the visualization of minute information of organ structures, more accurate material density measurement and improved tissue characterization. The demand for photon counting-CT is growing extensively with the growing incidence of numerous continual disorders. The demand for photon counting-CT is increasing rapidly with the rising prevalence of various chronic disorders. The outbreak of coronavirus has disturbed almost all the industries. But, due to COVID-19, the demand for effective diagnosis and treatment has spread across the globe. The rising demand for early detection of chronic diseases and lifestyle habits such as tobacco consumption, smoking and also the increasing air pollution levels will further increase the prevalence of cancer.
The exclusive COVID-19 impact analysis report by Axiom MRC provides a 360 degree analysis of micro and macro-economic factors on the North America photon counting CT market. In addition, complete analysis of changes on the North America photon counting CT market expenditure, economic and international policies on supply and demand side. The report also studies the impact of pandemic on North America economies, international trade, business investments, GDP and marketing strategies of key players present in the market.
North America Photon Counting CT Market-Segmental Overview
North America photon counting CT market includes different market segment like product type, application and end user and country.
By product type photon counting CT market is segmented into single channel counting system and multichannel counting system. The single channel counting system segment is expected to gain a major share in the global photon-counting CT market. In recent years, biomedical and chemical research has focused on optical analysis to better understand biological processes. Indeed, these non-invasive measures are the best solution for in vivo experiments as they allow the integrity of the analyzed sample to be preserved; In addition, they are particularly suitable in the medical field when diagnostic examinations are to be carried out on the patient. These following reasons are expected to propel the single channel counting system in the Photon Counting CT Market.
The photon counting CT market finds its major application in cardiology oncology, neurology and others. The cardiology segment is likely to dominate the North America photon-counting CT market due to the increasing demand for early diagnosis of cardiac disorders, rising incidences of risk factors such as obesity and sedentary lifestyle and increasing cases of stroke are leading to the growth of cardiology segment in the region. Another factor promoting market growth is the rising prevalence of coronary artery diseases and rising geriatric population the photon counting CT market in North America region is expected to grow at rapid pace in the forecast period.
The Photon Counting CT Market has different end user like Hospitals, Specialty Clinics, Imaging and Research Centers. In the North America region hospitals are leading the market due to increase in imbalanced lifestyle and adoption of unhealthy habits such as tobacco consumption, smoking are leading to increase the prevalence of cancer. The growing demand for premium healthcare infrastructure and significant improvements in imaging technologies are likely to drive the growth of the photon-counting CT market. Also the increase in the risk factors causing stroke such as obesity and sedentary lifestyle are rising in the region which are expected to propel the hospital segment in the region.
North America photon counting CT market is studied for the following countries like United States, Canada and Mexico. The demand for photon counting CT in region is rising due to increase in the geriatric population and rising prevalence in the region. Based on country, United States is expected to gain major market share during the estimated time period. The presence of key manufacturer in the country and rising demand for premium healthcare infrastructure and significant improvements in imaging technologies has increased the growth of photon counting CT market in the country.
The key players in Photon Counting CT Market are Picoquant, Becker & Hickl Gmbh, Hidex Oy, Id, Quantique (Idq), Photek, Thorlabs Inc., Ge Healthcare among others.
November 2020: GE Healthcare (NYSE:GE) said today that it has acquired Prismatic Sensors, a Swedish startup with deep silicon detector technology for photon-counting computed tomography (PCCT). hoton-counting CT technology, according to GE Healthcare, could expand the clinical capabilities of traditional CT — providing diagnostic benefits in clinical areas including oncology, cardiology and neurology. PCCT can enable the visualization of minute organ structure details, improved tissue characterization and more accurate material density measurement (or quantification). Plus, the radiation dose is lower.
September 2020: PicoQuant’s rapidFLIM HiRes combines ultra-fast FLIM imaging with outstanding 10 ps time resolution. Users can now visualize dynamic processes in cells or tissues with unprecedented acquisition speed and time resolution. Imaging dynamic processes in tissues or cells require methods that are fast, reliable, and quantitative. Scientists and engineers at PicoQuant have developed rapidFLIM HiRes which enables imaging samples at up to 15 frames per second with a time resolution of 10 ps using Fluorescence Lifetime Imaging (FLIM).
The report analyses the photon counting CT market based on different market segment like product type, application and end user and country. By product type photon counting CT market is segmented into single channel counting system and multichannel counting system. In North America the single channel counting system segment is expected to gain a major share due to its wide application in biomedical and chemical research which has focused on optical analysis to better understand biological processes. The photon counting CT market finds its major application in cardiology oncology, neurology and others. The cardiology is dominating the market due to of coronary artery diseases and increasing geriatric population. Also the sedentary lifestyle and adoption on unhealthy habits are increasing the prevalence of cancer in the region. The photon counting CT market has end user like Hospitals, Specialty Clinics, Imaging and Research Centers. In the North America region hospitals are leading the market due to increase in imbalanced lifestyle and adoption of unhealthy habits causing the increasing number of stroke and cancer cases the region. By country the United States is leading the market due to the presence of key manufacturers in the region and rising demand for premium healthcare infrastructure. The North America photon counting CT market is studied for the following countries like United States, Canada and Mexico.
